RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 8 analysts with an average price target of $266.83. This is a potential upside of $19.95 (8.08%) from yesterday's end of day stock price of $246.88.

ResMed's activity chart (see below) currently has 166 price targets and 139 ratings on display. The stock rating distribution of RMD is 45% HOLD and 55% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.66% with an average time for these price targets to be met of 168.78 days.

Highest price target for RMD is $330, Lowest price target is $240, average price target is $280.33.

Most recent stock forecast was given by SEAN LAAMAN from MORGAN STANLEY on 20-Oct-2025.

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Currently out of the existing stock ratings of RMD, 9 are a HOLD (45%), 11 are a BUY (55%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$304

$44.51 (17.15%)

$219

12 days ago
(20-Oct-2025)

6/7 (85.71%)

$35.78 (13.34%)

73

Buy

$330

$70.51 (27.17%)

$285

1 months 15 days ago
(17-Sep-2025)

7/8 (87.5%)

$56.71 (20.75%)

38

Buy

$270

$10.51 (4.05%)

$250

3 months 17 days ago
(15-Jul-2025)

14/14 (100%)

$16.28 (6.42%)

98

Buy

$290

$30.51 (11.76%)

6 months 9 days ago
(23-Apr-2025)

17/17 (100%)

$54.9 (23.35%)

363

Hold

$248

$-11.49 (-4.43%)

$260

6 months 9 days ago
(23-Apr-2025)

3/3 (100%)

$12.9 (5.49%)

70

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RMD (ResMed) average time for price targets to be met?

On average it took 168.78 days on average for the stock forecasts to be realized with a an average price target met ratio 71.66

Which analyst has the current highest performing score on RMD (ResMed) with a proven track record?

MATTHEW MISHAN

Which analyst has the most public recommendations on RMD (ResMed)?

Matthew Mishan works at KEYBANK and has 1 price targets and 3 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

Laura Sutcliffe with highest potential upside - $70.51

Which analyst is the currently most reserved on RMD (ResMed)?

Matt O'brien with lowest potential downside - -$202.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?